HHS Seeks Early Win Defending Medicare Drug Price Program
By Dan McKay · December 21, 2023, 7:24 PM EST
Boehringer Ingelheim and other drugmakers are free to take their business elsewhere if they object to the new Medicare price negotiation program, the federal government has said, urging a judge to...
To view the full article, register now.